Search Results - "Rocconi, R"

RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance by Somasagara, R R, Spencer, S M, Tripathi, K, Clark, D W, Mani, C, Madeira da Silva, L, Scalici, J, Kothayer, H, Westwell, A D, Rocconi, R P, Palle, K

“…Ovarian cancer (OC) is the most deadly gynecological cancer and unlike most other neoplasms, survival rates for OC have not significantly improved in recent…”
Get full text

Endometrial cancer as a platform for training residents in robotic hysterectomy techniques by Finan, M, Rocconi, R

Get full text

The trend towards minimally invasive surgery for endometrial cancer: An ASC-NSQIP evaluation of surgical outcomes by Laughlin, B, Lee, D, Finan, M, Rocconi, R

Get full text

Iron-modified albumin in cervical-vaginal fluid may lead to a screening test for endometrial cancer by Pannell, L, Billheimer, D, Schambeau, L, Blandford, J, Rocconi, R

Get full text

Is BRCA mutation screening a cost-effective strategy to improve targeted therapy in serous epithelial ovarian cancer? by Straughn, J, Estes, J, Leath, C, Finan, M, Rocconi, R

Get full text

Intraperitoneal port cytology after primary chemotherapy for ovarian cancer: A simple and inexpensive test to predict recurrence and survival by Dang, D, Long, B, Sullivan, P, Rocconi, R, Finan, M

Get full text

A novel method of screening for endometrial cancer by Finan, M, Pannell, L, Billheimer, D, Schambeau, L, Blandford, J, Rocconi, R

Get full text

Capillary lymphatic space (CLS) invasion in robotic vs abdominal hysterectomy for endometrial cancer by Finan, M, Boudreaux, C, Donnell, R, Gates, T, Klein, M, Lenz, C, Rocconi, R

Get full text

A novel hedgehog pathway smoothened inhibitor (BMS-833923) demonstrates in vitro synergy with carboplatin in ovarian cancer cells by Rocconi, R, Meng, E, Shevde, L, Finan, M, Reed, E

Get full text

Validation of a venous thromboembolism risk assessment model in gynecologic oncology by Rocconi, R, Stroud, W, Miklic, M, Whitworth, J, Matthews-Schneider, K, Reed, E, Bazzett, L, Straughn, J, Finan, M

Get full text

Identification and characterization of CD44+/CD24–ovarian cancer stem cell properties and their correlation with survival by Meng, E, Shevde, L, Long, B, Sullivan, P, McClellan, S, Finan, M, Reed, E, Rocconi, R

Get full text

Treatment of chemotherapy-induced anemia in patients with ovarian cancer: Does the use of erythropoiesis-stimulating agents worsen survival? by Rocconi, R, Long, B, Sullivan, P, Blaize, M, Brown, J, Arbuckle, J, Bevis, K, Estes, J, Reed, E, Finan, M

Get full text

A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer by Wright, J D, Secord, A A, Numnum, T M, Rocconi, R P, Powell, M A, Berchuck, A, Alvarez, R D, Gibb, R K, Trinkaus, K, Rader, J S, Mutch, D G

“…While bevacizumab has shown activity in recurrent ovarian cancer, a higher than expected incidence of bowel perforations has been reported in recent trials. We…”
Get more information

Postmenopausal uterine inversion associated with endometrial polyps by Rocconi, Rod, Huh, Warner K, Chiang, Seine

“…Postmenopausal uterine inversion is an extremely rare gynecologic complication. We report a case of uterine inversion associated with endometrial polyps alone…”
Get full text

Pegfilgrastim for the prevention of febrile neutropenia in patients with epithelial ovarian carcinoma--a cost-effectiveness analysis by Numnum, T M, Kimball, K J, Rocconi, R P, Kilgore, L C, Straughn, Jr, J M

“…The objective is to assess the cost-effectiveness of pegfilgrastim for the prevention of hospitalization due to febrile neutropenia (FN) in patients with…”
Get more information

Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents by Stoff-Khalili, M A, Rivera, A A, Le, L P, Stoff, A, Everts, M, Contreras, J L, Chen, D, Teng, L, Rots, M G, Haisma, H J, Rocconi, R P, Bauerschmitz, G J, Rein, D T, Yamamoto, M, Siegal, G P, Dall, P, Michael Mathis, J, Curiel, D T

“…Whereas virotherapy has emerged as a novel and promising approach for neoplastic diseases, appropriate model systems have hampered preclinical evaluation of…”
Get full text

Outcomes for patients with fallopian tube carcinoma managed with adjuvant chemotherapy following primary surgery: a retrospective university experience by Leath, 3rd, C A, Numnum, T M, Straughn, Jr, J M, Rocconi, R P, Huh, W K, Kilgore, L C, Partridge, E E

“…The aim is to evaluate disease-free (DFS) and overall survival (OS) of patients with fallopian tube carcinoma (FTCA) treated with adjuvant chemotherapy. An…”
Get more information

A cost–effectiveness analysis of chemotherapy for patients with recurrent platinum-sensitive epithelial ovarian cancer by Case, Ashley S, Rocconi, Rodney P, Partridge, Edward E, Straughn, J. Michael

“…Abstract Objective The majority of patients with advanced epithelial ovarian cancer (EOC) will experience a recurrence after primary chemotherapy and receive…”
Get full text

Outcomes of gynecologic oncology patients admitted to the intensive care unit following surgery: A university teaching hospital experience by Leath, 3rd, C A, Kendrick, 4th, J E, Numnum, T M, Straughn, Jr, J M, Rocconi, R P, Sfakianos, G P, Lang, Jr, J D

“…The objective of this study was to determine the outcomes of gynecological oncology patients requiring intensive care unit (ICU) admission following surgery. A…”
Get more information

818TiP Balstilimab alone or in combination with zalifrelimab as second-line treatment for patients with previously treated recurrent/metastatic cervical cancer (R/M CC): A randomized, placebo-controlled phase II trial (RaPiDS/GOG-3028) by Randall, L., O'Malley, D., Gunderson Jackson, C., Coleman, R.L., Hays, J., Moore, K.N., Naumann, R.W., Rocconi, R., Slomovitz, B., Tewari, K.S., Ancukiewicz, M., Ortuzar Feliu, W.I., Monk, B.J.

Get full text